TrialCancer medicine2021

R-COMP versus R-CHOP as first-line therapy for diffuse large B-cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group.

Juan-Manuel Sancho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.